A journal article was submitted detailing a study " percutaneous angioplasty in the treatment of thrombosed hemodialysis fistulas: a single-center experience with 1 year of follow-up".
33 patients were included in the study.
This study is an evaluation of the success and patency rate of percutaneous balloon angioplasty of thrombosed hemodialysis fistulas using a drug-coated balloon (dcb) contrasted with a standard balloon (sb).
Medtronic chocolate pta balloon catheter or a non-medtronic ptca balloon catheter were used in the sb group and a non-medtronic dcb were used in the dcb group.
Sb angioplasty was performed with an inflation time of 2minutes at nominal pressure (6 or 9 atm).
In the dcb group, pre dilation with a sb was followed by angioplasty with a dcb with an inflation time of 2 minutes at 6 atm.
Restenosis were reported in the population at 1, 6 and 12 months post procedure.
1 patient in each group died within 6 months post procedure.
At 12 months, one additional patient of each group died.
Two patients in each group died due to cardiovascular causes during the follow up period.
A minor access site hematoma developed in 3 patients: 1 in a femoral access site and 2 in a brachial access site.
The patients were treated conservatively without any need for blood transfusion or surgica l treatment.
In 1 patient, angioplasty balloon fracture and embolization occurred during the procedure, however, the embolized part of the balloon was retrieved using a snare catheter without the need for surgery.
There was no procedural complication requiring urgent surgery.
|